Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001834150-26-000006·Upstream Bio, Inc.
Schedule 13G ownership disclosure
Upstream Bio Inc
Common Stock, par value $0.001 per share · CUSIP: 91678A107
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Decheng Capital Global Life Sciences Fund IV, L.P.
Shares: 2,724,868.00 · Class: 4.9%
- Decheng Capital Management IV (Cayman), LLC
Shares: 2,724,868.00 · Class: 4.9%
- Xiangmin Cui
Shares: 2,724,868.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001834150-26-000006
- Form type
- SCHEDULE 13G/A
- Filer
- Upstream Bio, Inc.
- CIK
- CIK 2022626
- Filed
- Oct 29, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership